166 related articles for article (PubMed ID: 31002358)
1. A 19‑miRNA Support Vector Machine classifier and a 6‑miRNA risk score system designed for ovarian cancer patients.
Dong J; Xu M
Oncol Rep; 2019 Jun; 41(6):3233-3243. PubMed ID: 31002358
[TBL] [Abstract][Full Text] [Related]
2. A 21‑gene Support Vector Machine classifier and a 10‑gene risk score system constructed for patients with gastric cancer.
Jiang H; Gu J; Du J; Qi X; Qian C; Fei B
Mol Med Rep; 2020 Jan; 21(1):347-359. PubMed ID: 31939629
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a SVM classifier to predict recurrence of ovarian cancer.
Zhou J; Li L; Wang L; Li X; Xing H; Cheng L
Mol Med Rep; 2018 Oct; 18(4):3589-3598. PubMed ID: 30106117
[TBL] [Abstract][Full Text] [Related]
4. Prediction of candidate RNA signatures for recurrent ovarian cancer prognosis by the construction of an integrated competing endogenous RNA network.
Wang X; Han L; Zhou L; Wang L; Zhang LM
Oncol Rep; 2018 Nov; 40(5):2659-2673. PubMed ID: 30226545
[TBL] [Abstract][Full Text] [Related]
5. Signature microRNAs and long noncoding RNAs in laryngeal cancer recurrence identified using a competing endogenous RNA network.
Tang Z; Wei G; Zhang L; Xu Z
Mol Med Rep; 2019 Jun; 19(6):4806-4818. PubMed ID: 31059106
[TBL] [Abstract][Full Text] [Related]
6. A random forest classifier predicts recurrence risk in patients with ovarian cancer.
Cheng L; Li L; Wang L; Li X; Xing H; Zhou J
Mol Med Rep; 2018 Sep; 18(3):3289-3297. PubMed ID: 30066910
[TBL] [Abstract][Full Text] [Related]
7. An 8 miRNA-Based Risk Score System for Predicting the Prognosis of Patients With Papillary Thyroid Cancer.
Yi W; Liu J; Qu S; Fan H; Lv Z
Technol Cancer Res Treat; 2020; 19():1533033820965594. PubMed ID: 33054579
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of miR-145-5p in cancer cells and their derived exosomes may contribute to the development of ovarian cancer by targeting CT.
Hang W; Feng Y; Sang Z; Yang Y; Zhu Y; Huang Q; Xi X
Int J Mol Med; 2019 Jan; 43(1):256-266. PubMed ID: 30365097
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a five-microRNA signature as a prognostic biomarker for esophageal squamous cell carcinoma.
Yu J; Zhu M; Lv M; Wu X; Zhang X; Zhang Y; Li J; Zhang Q
Sci Rep; 2019 Dec; 9(1):19847. PubMed ID: 31882677
[TBL] [Abstract][Full Text] [Related]
10. Identification of exosomal and non‑exosomal microRNAs associated with the drug resistance of ovarian cancer.
Feng Y; Hang W; Sang Z; Li S; Xu W; Miao Y; Xi X; Huang Q
Mol Med Rep; 2019 May; 19(5):3376-3392. PubMed ID: 30864705
[TBL] [Abstract][Full Text] [Related]
11. A 15-gene signature for prediction of colon cancer recurrence and prognosis based on SVM.
Xu G; Zhang M; Zhu H; Xu J
Gene; 2017 Mar; 604():33-40. PubMed ID: 27998790
[TBL] [Abstract][Full Text] [Related]
12. Serum miR-1181 and miR-4314 associated with ovarian cancer: MiRNA microarray data analysis for a pilot study.
Ruan L; Xie Y; Liu F; Chen X
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():31-38. PubMed ID: 29353130
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study.
Bagnoli M; Canevari S; Califano D; Losito S; Maio MD; Raspagliesi F; Carcangiu ML; Toffoli G; Cecchin E; Sorio R; Canzonieri V; Russo D; Scognamiglio G; Chiappetta G; Baldassarre G; Lorusso D; Scambia G; Zannoni GF; Savarese A; Carosi M; Scollo P; Breda E; Murgia V; Perrone F; Pignata S; De Cecco L; Mezzanzanica D;
Lancet Oncol; 2016 Aug; 17(8):1137-1146. PubMed ID: 27402147
[TBL] [Abstract][Full Text] [Related]
14. Construction of a 26‑feature gene support vector machine classifier for smoking and non‑smoking lung adenocarcinoma sample classification.
Yang L; Sun L; Wang W; Xu H; Li Y; Zhao JY; Liu DZ; Wang F; Zhang LY
Mol Med Rep; 2018 Feb; 17(2):3005-3013. PubMed ID: 29257283
[TBL] [Abstract][Full Text] [Related]
15. A 80-gene set potentially predicts the relapse in laryngeal carcinoma optimized by support vector machine.
Yang B; Guo Q; Wang F; Cai K; Bao X; Chu J
Cancer Biomark; 2017; 19(1):65-73. PubMed ID: 28269752
[TBL] [Abstract][Full Text] [Related]
16. A six‑gene support vector machine classifier contributes to the diagnosis of pediatric septic shock.
Long G; Yang C
Mol Med Rep; 2020 Mar; 21(3):1561-1571. PubMed ID: 32016447
[TBL] [Abstract][Full Text] [Related]
17. Competing endogenous RNA regulatory network in papillary thyroid carcinoma.
Chen S; Fan X; Gu H; Zhang L; Zhao W
Mol Med Rep; 2018 Jul; 18(1):695-704. PubMed ID: 29767230
[TBL] [Abstract][Full Text] [Related]
18. Molecular Signature for Lymphatic Invasion Associated with Survival of Epithelial Ovarian Cancer.
Paik ES; Choi HJ; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
Cancer Res Treat; 2018 Apr; 50(2):461-473. PubMed ID: 28546526
[TBL] [Abstract][Full Text] [Related]
19. Screening the molecular targets of ovarian cancer based on bioinformatics analysis.
Du L; Qian X; Dai C; Wang L; Huang D; Wang S; Shen X
Tumori; 2015; 101(4):384-9. PubMed ID: 25953442
[TBL] [Abstract][Full Text] [Related]
20. Glycosylation-Related Genes Predict the Prognosis and Immune Fraction of Ovarian Cancer Patients Based on Weighted Gene Coexpression Network Analysis (WGCNA) and Machine Learning.
Zhao C; Xiong K; Zhao F; Adam A; Li X
Oxid Med Cell Longev; 2022; 2022():3665617. PubMed ID: 35281472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]